USPTO serial 79396077
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven J. Solomon
Steven J. Solomon Tucker Ellis LLP950 Main Avenue, Suite 1100Cleveland, OH 44113United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; chemicals for use in industry, specifically for biotechnological product development; chemical additives used in the manufacture of medicines or other active chemical ingredients; chemical and biological preparations for use in industry and science; none of the aforementioned products relating to the veterinary field and animal health. | ACTIVE | — |
| 005 | Pharmaceutical preparations for treatment of cancers, namely, lung cancer, colorectal cancer, stomach cancer, esophageal cancer, cervical cancer, breast cancer, pancreatic cancer, prostate cancer; sanitary preparations for medical use; chemical and biological preparations for pharmaceutical use for the treatment of cancers, namely, lung cancer, colorectal cancer, stomach cancer, esophageal cancer, cervical cancer, breast cancer, pancreatic cancer, prostate cancer; biological reagents for medical purposes; radioactive pharmaceutical preparations for use in in vivo diagnostics; pharmaceutical preparations for medical use, specifically for the treatment of cancers namely, lung cancer, colorectal cancer, stomach cancer, esophageal cancer, cervical cancer, breast cancer, pancreatic cancer, prostate cancer; biological preparations for diagnosis of cancers, namely, lung cancer, colorectal cancer, stomach cancer, esophageal cancer, cervical cancer, breast cancer, pancreatic cancer, prostate cancer; biological and pharmaceutical preparations for the prevention and treatment of cancer; human immunoglobulin being pharmaceutical preparations for the treatment of cancer, and inflammatory and infectious diseases; none of the aforementioned products relating to the veterinary field and animal health. | ACTIVE | — |
| 042 | Biotechnology research; biological research, clinical research in the field of cancer, and inflammatory and infectious diseases; medical research; medical research laboratory services; none of the aforementioned services relating to the veterinary field and animal health. | ACTIVE | — |
| 044 | Collection and preservation of human biological tissue, blood and cells; medical diagnostic services; medical treatment services; medical testing for diagnostic or treatment purposes; medical analysis services for the diagnosis and treatment of persons; analysis and treatment of blood plasma and stem cells being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing information and data for medical diagnosis and treatment; providing information in the field of cancer prevention, screening, diagnosis and treatment; none of the aforementioned services relating to the veterinary field and animal health | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 19, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 19, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 19, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 31, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 5, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 5, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 5, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 5, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 7, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 22, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 22, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 14, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 28, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 28, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 28, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 28, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 2, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 2, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 29, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 28, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 29, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 29, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 23, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |